» Articles » PMID: 33572792

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate

Overview
Date 2021 Feb 12
PMID 33572792
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress plays critical roles in the pathogenesis of diabetes. This study tested the hypothesis that by protecting β-cells against oxidative stress and inflammation, an Nrf2 activator, dimethyl fumarate (DMF), may prevent or delay the onset of type 1 diabetes in non-obese diabetic (NOD) mice. Firstly, islet isolation was conducted to confirm the antioxidative effects of DMF oral administration on islet cells. Secondly, in a spontaneous diabetes model, DMF (25 mg/kg) was fed to mice once daily starting at the age of 8 weeks up to the age of 22 weeks. In a cyclophosphamide-induced accelerated diabetes model, DMF (25 mg/kg) was fed to mice twice daily for 2 weeks. In the islet isolation study, DMF administration improved the isolation yield, attenuated oxidative stress and enhanced GCLC and NQO1 expression in the islets. In the spontaneous model, DMF significantly reduced the onset of diabetes compared to the control group (25% vs. 54.2%). In the accelerated model, DMF reduced the onset of diabetes from 58.3% to 16.7%. The insulitis score in the islets of the DMF treatment group (1.6 ± 0.32) was significantly lower than in the control group (3.47 ± 0.21). The serum IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-12p70, IFN-γ, TNF-α, MCP-1 and CXCL16 levels in the DMF-treated group were lower than in the control group. In conclusion, DMF may protect islet cells and reduce the incidence of autoimmune diabetes in NOD mice by attenuating insulitis and proinflammatory cytokine production.

Citing Articles

The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.

Maiese K Front Immunol. 2023; 14:1273570.

PMID: 38022638 PMC: 10663950. DOI: 10.3389/fimmu.2023.1273570.


Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK.

Maiese K Cells. 2023; 12(22).

PMID: 37998330 PMC: 10670256. DOI: 10.3390/cells12222595.


Novel potential pharmacological applications of dimethyl fumarate-an overview and update.

Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M Front Pharmacol. 2023; 14:1264842.

PMID: 37745068 PMC: 10512734. DOI: 10.3389/fphar.2023.1264842.


4-Octyl itaconate attenuates glycemic deterioration by regulating macrophage polarization in mouse models of type 1 diabetes.

He S, Zhao Y, Wang G, Ke Q, Wu N, Lu L Mol Med. 2023; 29(1):31.

PMID: 36918798 PMC: 10015936. DOI: 10.1186/s10020-023-00626-5.


Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes.

Yang M, Kibbey R, Mamula M Front Immunol. 2022; 13:1028130.

PMID: 36389721 PMC: 9647083. DOI: 10.3389/fimmu.2022.1028130.


References
1.
Berney T, Molano R, Cattan P, Pileggi A, Vizzardelli C, Oliver R . Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation. 2001; 71(1):125-32. DOI: 10.1097/00007890-200101150-00020. View

2.
Campolo M, Casili G, Biundo F, Crupi R, Cordaro M, Cuzzocrea S . The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2. Antioxid Redox Signal. 2016; 27(8):453-471. PMC: 5564046. DOI: 10.1089/ars.2016.6800. View

3.
Takeda T, Tsubaki M, Asano R, Itoh T, Imano M, Satou T . Dimethyl fumarate suppresses metastasis and growth of melanoma cells by inhibiting the nuclear translocation of NF-κB. J Dermatol Sci. 2020; 99(3):168-176. DOI: 10.1016/j.jdermsci.2020.07.004. View

4.
Guo Y, Xie J, Rubin E, Tang Y, Lin F, Zi X . Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling. Cancer Res. 2008; 68(9):3350-60. PMC: 2824245. DOI: 10.1158/0008-5472.CAN-07-3220. View

5.
Yagishita Y, Uruno A, Chartoumpekis D, Kensler T, Yamamoto M . Nrf2 represses the onset of type 1 diabetes in non-obese diabetic mice. J Endocrinol. 2019; . PMC: 6602871. DOI: 10.1530/JOE-18-0355. View